It is well-known that in many tumors, the combination of PD-L1 on tumor cells with PD-1 on activated T cells causes T cell dysfunction and thus suppresses anti-tumor immunity, which is called T cell “exhaustion”9–12,28. Here, PDCD1 is linked to neoplasm.